Results of giant cell tumor of bone treated with intralesional excision

Clinical Orthopaedics and Related Research
Paul SaizS Gitelis

Abstract

Treatment of giant cell tumor of bone ranges from intralesional curettage to en bloc resection. We think that intralesional treatment can be done with low recurrence and complication rates and that these patients have good functional results. The results for 40 patients treated by one surgeon with one technique for giant cell tumor of bone between 1985-1999 were reviewed. All patients were treated with intralesional excision of the tumor with adjunctive cautery, phenol, and methylmethacrylate. All patients had been followed up for a minimum of 2 years with the mean followup of 76 months (range, 26-178 months). In addition, recent functional evaluations were done on 23 patients at a mean followup of 90 months (range, 28-175 months). The local recurrence rate was 12.5%. The nononcologic complication rate was 7.5%. Using the Musculoskeletal Tumor Society functional evaluation, 93% of the patients had excellent results. This long-term followup study on patients treated with intralesional excision and methacrylate showed a low recurrence rate similar to those cited in the literature. Additionally, the complication rate was low and the function results were excellent.

References

Apr 1, 1984·Acta Orthopaedica Scandinavica·B M PerssonB Gunterberg
Dec 1, 1994·The Journal of Bone and Joint Surgery. American Volume·R J O'DonnellH J Mankin
Dec 1, 1994·Journal of Surgical Oncology·A J RenardJ R van Horn
Nov 1, 1993·The Journal of Bone and Joint Surgery. American Volume·S GitelisF Turner
Jan 1, 1993·Archives of Orthopaedic and Trauma Surgery·S Komiya, A Inoue
Aug 15, 1998·Japanese Journal of Clinical Oncology·Y OdaY Iwamoto
Mar 17, 1999·Clinical Orthopaedics and Related Research·M M MalawerY Kollender
Jul 3, 1999·The Journal of Bone and Joint Surgery. American Volume·H R BlackleyR S Bell
Nov 11, 1999·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H R DürrH J Refior
Feb 24, 2001·Clinical Orthopaedics and Related Research·C Y ChengR W Hsu
Apr 6, 2001·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K TriebR Kotz
Apr 16, 2002·Clinical Orthopaedics and Related Research·Robert E TurcotteUNKNOWN Canadian Sarcoma Group
Apr 16, 2002·Clinical Orthopaedics and Related Research·William G Ward, Galaxy Li
Jun 20, 2002·Clinical Orthopaedics and Related Research·Michelle A GhertSean P Scully

❮ Previous
Next ❯

Citations

Sep 1, 2005·Clinical Orthopaedics and Related Research·Richard D LackmanEdward J Fox
Sep 8, 2006·Clinical Orthopaedics and Related Research·Valerae O LewisMichael A Simon
Jul 7, 2011·Clinical Orthopaedics and Related Research·Wei-Hsin LinRong-Sen Yang
Jan 27, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A López-PousaJ Vázquez
Oct 25, 2016·Skeletal Radiology·Alireza EajaziDaniel Ira Rosenthal
Apr 6, 2017·World Journal of Surgical Oncology·Zhenhua ZhouJianru Xiao
Oct 11, 2019·Rare Tumors·Ziyad M MohaidatZiad A Audat
Apr 28, 2007·Avian Diseases·Olga AmannNico J Schoemaker
Nov 30, 2011·Clinical Orthopaedics and Related Research·Thomas J KremenJeffrey J Eckardt
Mar 7, 2008·Journal of Cancer Research and Clinical Oncology·Maurice BalkeGeorg Gosheger
Jul 10, 2012·Clinical Orthopaedics and Related Research·Yu-Peng LiuBu-Hua Sun
Mar 30, 2016·Skeletal Radiology·Judy SarungbamMeera Hameed
Dec 30, 2014·Acta ortopedica brasileira·André Mathias BaptistaOlavo Pires de Camargo
Oct 27, 2017·Chinese Medical Journal·Kai ZhengUNKNOWN Giant Cell Tumor Group of China (GTOC)
Feb 8, 2006·American Journal of Clinical Oncology·William M MendenhallNancy P Mendenhall
Sep 22, 2010·Clinical Orthopaedics and Related Research·Frank M KlenkeFranklin H Sim
Nov 7, 2008·Clinical Orthopaedics and Related Research·Richard D LackmanChristian M Ogilvie
May 2, 2014·Journal of Orthopaedic Surgery·Manasseh NithyananthVernon N Lee
May 20, 2016·Brain Tumor Research and Treatment·Dae Hwan Kim, Chang Ki Hong
Mar 16, 2007·The Journal of Bone and Joint Surgery. British Volume·F Vult von SteyernA Rydholm
Aug 14, 2010·Clinical Orthopaedics and Related Research·Frank M KlenkeFranklin H Sim
Apr 10, 2007·Clinical Orthopaedics and Related Research·Benjamin M DeheshiJay S Wunder
Feb 24, 2009·Acta Orthopaedica·Martti HirnSimon R Carter
Aug 25, 2010·Archives of Orthopaedic and Trauma Surgery·Won Seok SongDae-Geun Jeon
Mar 9, 2012·The Journal of Bone and Joint Surgery. American Volume·Xiaohui NiuWeifeng Liu
Feb 10, 2007·Clinical Orthopaedics and Related Research·Tamir PritschMartin M Malawer
Oct 24, 2020·International Orthopaedics·Gennady N Machak, Andrey I Snetkov
Aug 17, 2021·Frontiers in Surgery·Yushan WangYi Feng
Aug 13, 2011·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Kabul Chandra SaikiaFiroz Ahmed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Bone and Joint Surgery. American Volume
S GitelisF Turner
Clinical Orthopaedics and Related Research
Florian MittermayerRainer Kotz
Clinical Orthopaedics and Related Research
Richard D LackmanChristian M Ogilvie
© 2022 Meta ULC. All rights reserved